Access cutting-edge heart failure treatment through this clinical trial at a research site in Valencia. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Valencia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: * Vicadrostat and empagliflozin
Sponsor: Boehringer Ingelheim
Check if you qualify for this heart failure clinical trial in Valencia, CA
If you're searching for heart failure treatment options in Valencia, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Valencia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.